Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial,The American Journal on Addictions

当前位置： X-MOL 学术 › The American Journal on Addictions › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial
The American Journal on Addictions ( IF 2.5 ) Pub Date : 2021-09-06 , DOI: 10.1111/ajad.13151
Arild Opheim _{1,

2} , Zhanna Gaulen _{1,

3} , Kristin Klemmetsby Solli _{4,

5,

6} , Zill‐e‐Huma Latif ₇ , Lars T. Fadnes _{1,

2} , Jūratė Šaltytė Benth _{8,

9} , Nikolaj Kunøe ₁₀ , Lars Tanum _{5,

11}

Affiliation

Compare the risk of relapse to heroin and other illicit opioids among opioid-dependent patients receiving treatment with extended-release naltrexone (XR-NTX) or buprenorphine-naloxone (BP-NLX).

中文翻译：